Keyphrases
Blindness
12%
Cost-utility Analysis
12%
Direct Medical Costs
12%
Drug Nephrotoxicity
12%
End-stage Renal Disease
25%
Euglycemia
12%
Health Status
12%
Incremental Cost
12%
Insulin Therapy
25%
Life Expectancy
25%
Markov Model
12%
Non-uremic
100%
Overt Nephropathy
12%
Pancreas
25%
Pancreas Graft
12%
Pancreas Transplant
12%
Pancreas Transplantation
100%
Patients at Risk
12%
Progression Rate
12%
Quality-adjusted Life Years
25%
Renal Complications
12%
Renal Disease
12%
Retinal Complications
12%
Retinal Diseases
12%
Standard Gamble
12%
Therapeutic Potential
12%
Type 1 Diabetes Mellitus (T1DM)
100%
Type 1 Diabetic Patient
25%
Utility Score
12%
Vascular Complications
12%
Medicine and Dentistry
Amaurosis
10%
Diabetes Mellitus
20%
Disease
10%
End Stage Renal Disease
20%
Health Care Cost
40%
Health Status
10%
Insulin Dependent Diabetes Mellitus
100%
Insulin Treatment
20%
Life Expectancy
20%
Nephropathy
20%
Nephrotoxicity
10%
Pancreas Transplantation
100%
Patient with Type 1 Diabetes
100%
Quality Adjusted Life Year
20%
Renal Agent
10%
Retina Disease
10%
Standard Gamble
10%